4.7 Review

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases

Garima Sharma et al.

Summary: The revolutionary CRISPR-Cas9 technology has therapeutic potential against genetic disorders and is being tested in clinical trials for cancer treatment. In addition to therapeutic applications, it can also be used to create genetic animal models for drug discovery. However, challenges and safety concerns still need to be addressed in CRISPR-Cas9-mediated therapeutic approaches.

MOLECULAR THERAPY (2021)

Article Medicine, Research & Experimental

ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis

Hao Yu et al.

Summary: In bladder cancer, downregulation of ALKBH5 is associated with worse prognosis, and knockdown of ALKBH5 promotes cell proliferation, migration, and invasion while decreasing sensitivity to cisplatin chemotherapy. ALKBH5 inhibits bladder cancer progression and sensitizes cells to cisplatin through regulation of the m6A-dependent casein kinase 2 (CK2)α-mediated glycolysis pathway.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Cell Biology

ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma

Lili Hao et al.

Summary: The study revealed that high expression of ALKBH5 is associated with poor outcome in uveal melanoma. ALKBH5 promotes UM progression by demethylating FOXM1 mRNA, potentially inducing EMT for cell metastasis.

AGING-US (2021)

Article Oncology

ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment

Feng Dong et al.

Summary: This study reveals that hypoxia-induced upregulation of m(6)A demethylase ALKBH5 leads to the formation of NEAT1-mediated paraspeckles, resulting in increased CXCL8/IL8 expression and enhanced TAM recruitment and tumor progression in GBM. The findings provide evidence for the link between hypoxia-induced epitranscriptomic changes and the formation of an immunosuppressive microenvironment.

CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Golnaz Morad et al.

Summary: This passage discusses the unprecedented advances in cancer treatment with immune checkpoint blockade (ICB), highlighting the critical need for insights into factors intrinsic and extrinsic to the host that impact ICB response and toxicity. There has been substantial progress in understanding the impact of host-intrinsic factors and the exposome on host physiology and response to treatment, representing the hallmarks of response, resistance, and toxicity to ICB in current day.
Article Cell Biology

ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma

Ye Yuan et al.

Summary: ALKBH5 is the main enzyme responsible for m(6)A-based demethylation of RNAs and has been associated with various biological and pathophysiological processes. In osteosarcoma, downregulated levels of ALKBH5 were correlated with increased m(6)A methylation, leading to enhanced cancer progression. ALKBH5 overexpression suppressed osteosarcoma cell growth, migration, and invasion by regulating the m(6)A methylation of specific RNA molecules, suggesting a potential therapeutic approach for osteosarcoma treatment.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma

Runping Fang et al.

Summary: In this study, it was revealed that YTHDF2 overexpression is associated with poor prognosis in glioma patients due to EGFR-induced protein stabilization, leading to reduced cholesterol homeostasis and promoting GBM tumorigenesis through an RNA m6A methylation dependent mechanism.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma

Jinliang Xue et al.

Summary: The study revealed a novel positive feedback regulation between miR-193a-3p and ALKBH5 in esophageal squamous cell carcinoma, promoting the proliferation, migration, and invasion ability of tumor cells.

HUMAN CELL (2021)

Article Oncology

ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response

Genwen Chen et al.

Summary: The study revealed the important role of m6A methylation in regulating the STING-interferon regulatory factor 3 signaling in radiation-induced liver diseases, with ALKBH5 and HMGB1 playing crucial roles. These findings contribute to a better understanding of the mechanisms of liver injury caused by radiation therapy.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Oncology

The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells

Aline Kowalski-Chauvel et al.

Summary: The study found that the overexpression of m6A RNA demethylase ALKBH5 in GBMSCs increases their resistance to radiation and promotes their invasive ability by controlling homologous recombination. Therefore, inhibiting ALKBH5 may be an effective therapeutic approach to overcome the radioresistance and invasiveness of GBMSCs.

CANCERS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA

Benyu Liu et al.

Summary: The newly identified circular RNA circZbtb20 is crucial for the maintenance and function of group 3 innate lymphoid cells (ILC3), with its deletion causing reduced ILC3 numbers and increased susceptibility to bacterial infections. The circZbtb20 enhances the stability of specific mRNA and initiates a signaling pathway to maintain the homeostasis of ILC3.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment

Zhenbo Han et al.

Summary: This study reveals a previously unidentified role of m6A demethylase ALKBH5 in determining the cardiac lineage commitment of human embryonic stem cells, by regulating the components of H3K4 modifying enzyme complexes and enhancing the transcription of GATA4. Loss of function of ALKBH5 alters the expression of KDM5B and RBBP5 through impairing the stability of their mRNAs, which promotes the transcription of GATA4 by enhancing histone H3 Lys4 trimethylation at the promoter region.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Biochemistry & Molecular Biology

ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma

Hui Yu et al.

Summary: Lung adenocarcinomas have increased RMRP expression, which is associated with poor prognosis. ALKBH5 upregulates RMRP expression via demethylation, indicating that targeting RMRP through ALKBH5 manipulation could be a promising therapeutic strategy for lung adenocarcinoma.

MAMMALIAN GENOME (2021)

Article Multidisciplinary Sciences

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova et al.

Summary: The study identified a highly potent and selective catalytic inhibitor of METTL3, STM2457, which shows potential therapeutic value in treating AML. Treatment with this inhibitor leads to reduced AML growth, increased differentiation and apoptosis, and decreased m(6)A levels on leukemogenic mRNAs. In vivo pharmacological inhibition of METTL3 results in impaired engraftment and prolonged survival in mouse models of AML.

NATURE (2021)

Article Oncology

被撤回的出版物: miRNA-193a-3p Regulates the AKT2 Pathway to Inhibit the Growth and Promote the Apoptosis of Glioma Cells by Targeting ALKBH5 (Retracted article. See vol. 11, 2021)

Yong Cui et al.

Summary: miR-193a-3p plays a crucial role in glioma cells by inhibiting tumor growth and promoting apoptosis through the suppression of ALKBH5 and AKT2 expression. The antitumor effects are mediated by the AKT2-induced intrinsic apoptosis signaling pathway.

FRONTIERS IN ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors

Simona Selberg et al.

Summary: Two new ALKBH5 inhibitors were found to significantly suppress the proliferation of leukemia cell lines, with IC50 values ranging from 1.38 to 16.5 μM. However, the effect on another leukemia cell line and glioblastoma cell line was minimal. This demonstrates the potential of ALKBH5 inhibition as a selective antiproliferative strategy for certain cancer cell types.

ACS OMEGA (2021)

Article Oncology

Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A

Yongchao Zhao et al.

Summary: The study revealed that ALKBH5 acts as a negative regulator in post-ischemic angiogenesis, modulating WNT5A mRNA stability in an m6A-dependent manner. Targeting ALKBH5 may be a potential therapeutic option for ischemic diseases.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Oncology

A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis

Siming Qu et al.

Summary: ALKBH5 is overexpressed in HBV-related HCC tissues and predicts poor prognosis. The increased ALKBH5 expression is induced by HBx-mediated H3K4me3 modification in a WDR5-dependent manner after HBV infection, leading to m(6)A demethylation of HBx mRNA and stabilization of HBx expression. Positive correlations between HBx and ALKBH5 were observed in HBV-HCC tissues, and targeting ALKBH5 may provide a potential way for HBV-HCC treatment.

BMC CANCER (2021)

Article Oncology

M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Xinyao Qiu et al.

Summary: This study identifies PD-L1 mRNA as a target of ALKBH5 and reveals a role for ALKBH5 in regulating the tumor immune microenvironment and immunotherapy efficacy. These findings suggest a new regulatory mechanism for PD-L1 involving mRNA epigenetic modification by ALKBH5, as well as a potential role for ALKBH5 in cancer immunotherapies.

CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability

Lingling Feng et al.

Summary: This study demonstrates that ALKBH5 is upregulated during osteogenesis and promotes osteogenesis by modulating the stability of Runx2 mRNA.

FEBS LETTERS (2021)

Article Oncology

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NE-κB and promote the malignant progression of glioma

Rui-Chao Chai et al.

Summary: YTHDF2 expression is positively associated with higher malignant grade and molecular subtype of glioma, and poorer prognosis. YTHDF2 promotes the malignant progression of gliomas by accelerating UBXN1 mRNA degradation via METTL3-mediated m(6)A modification, which in turn promotes NF-kappa B activation.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Medicine, Research & Experimental

m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease

Binyu Wang et al.

Summary: ALKBH5 plays a crucial role in the occurrence of HSCR by demethylating TAGLN mRNA and up-regulating its expression to inhibit the proliferation and migration of enteric neural crest cells.

LIFE SCIENCES (2021)

Article Biochemistry & Molecular Biology

ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD

Zhifeng Liu et al.

Summary: This study revealed that the upregulation of ALKBH5 in glioma promotes cell proliferation by demethylating G6PD and enhancing PPP activity. ALKBH5 could serve as a potential therapeutic target for glioma.

NEUROCHEMICAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response

Fang Yu et al.

Summary: The RNA demethylase ALKBH5 serves as a key regulator in protecting cells from DNA damage and apoptosis during ROS-induced stress. ROS induces global mRNA N-6-methyladenosine levels by modulating ALKBH5 post-translational modifications, leading to the rapid induction of genes involved in DNA damage repair. Additionally, ROS activates the ERK/JNK/ALKBH5-PTMs/m(6)A axis in hematopoietic stem/progenitor cells in mice, indicating a physiological role of this pathway in maintaining genome stability.

NUCLEIC ACIDS RESEARCH (2021)

Article Cell Biology

Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer

Donghong Zhang et al.

Summary: The decreased levels of m6A in KRAS-mutated lung cancer patients are associated with disease progression and poor survival, mainly due to an increase in ALKBH5. Loss of LKB1 promotes ALKBH5 transcription through a DNA methylation mechanism, reducing m6A modification and increasing the stability of m6A target oncogenes.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

N6-methyladenosine binding induces a metal-centered rearrangement that activates the human RNA demethylase Alkbh5

Jeffrey A. Purslow et al.

Summary: Alkbh5 catalyzes demethylation of m(6)A, an epigenetic mark controlling physiological processes. Study shows m(6)A binding induces metal center rearrangement in Alkbh5, increasing oxygen binding capacity.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity

Jing Zhou et al.

Summary: The m(6)A eraser ALKBH5 plays a crucial role in controlling the pathogenicity of CD4(+) T cells during autoimmunity, as its deficiency results in weakened immune responses and reduced recruitment of neutrophils into the central nervous system.

SCIENCE ADVANCES (2021)

Review Biochemistry & Molecular Biology

Viral vector platforms within the gene therapy landscape

Jote T. Bulcha et al.

Summary: The field of gene therapy has made significant progress in combating human diseases and providing hope to patients and families with limited treatment options, but it has also faced setbacks. Viral-based vectors have played a crucial role in developing powerful drug platforms, but challenges still limit their full potential.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1

Zhenbo Han et al.

Summary: The study reveals the significant role of m(6)A RNA modification in heart regeneration, with the ALKBH5-m(6)A-YTHDF1-YAP axis regulating cardiomyocytes to re-enter the cell cycle. This finding offers a novel therapeutic strategy for cardiac regeneration.

THERANOSTICS (2021)

Article Oncology

ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer

Peipei Yang et al.

PATHOLOGY & ONCOLOGY RESEARCH (2020)

Article Biochemistry & Molecular Biology

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

Omprakash Shriwas et al.

APOPTOSIS (2020)

Article Biochemistry & Molecular Biology

ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia

Yinghui Chao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line

Alessio Malacrida et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Review Genetics & Heredity

Engineering adeno-associated virus vectors for gene therapy

Chengwen Li et al.

NATURE REVIEWS GENETICS (2020)

Review Medicine, Research & Experimental

Cancer immunotherapy: Pros, cons and beyond

Shuzhen Tan et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Chemistry, Medicinal

Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer

Rajiv K. Bedi et al.

CHEMMEDCHEM (2020)

Article Biochemistry & Molecular Biology

Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein

Jiexin Li et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Biochemistry & Molecular Biology

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

Sajid Khan et al.

ONCOGENE (2020)

Article Biochemistry & Molecular Biology

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Yunhao Chen et al.

MOLECULAR CANCER (2020)

Article Biotechnology & Applied Microbiology

Programmable m6A modification of cellular RNAs with a Cas13-directed methyltransferase

Christopher Wilson et al.

NATURE BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

Na Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Oncology

Key steps for effective breast cancer prevention

Kara L. Britt et al.

NATURE REVIEWS CANCER (2020)

Article Pharmacology & Pharmacy

N-6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury

Kaiwei Xu et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)

Review Gastroenterology & Hepatology

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances

Alphonse E. Sirica et al.

HEPATOLOGY (2019)

Review Cell Biology

Regulation of microRNA biogenesis and its crosstalk with other cellular pathways

Thomas Treiber et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Chemistry, Multidisciplinary

Identification of Flavin Mononucleotide as a Cell-Active Artificial N6-Methyladenosine RNA Demethylase

Li-Jun Xie et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Review Oncology

HIF Inhibitors: Status of Current Clinical Development

Jaleh Fallah et al.

CURRENT ONCOLOGY REPORTS (2019)

Article Oncology

ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2

Hongtao Zhu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1

Jun Zhang et al.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG

Katherine I. Zhou et al.

MOLECULAR CELL (2019)

Article Biochemistry & Molecular Biology

N6-Methyladenosine Modification Controls Circular RNA Immunity

Y. Grace Chen et al.

MOLECULAR CELL (2019)

Review Biotechnology & Applied Microbiology

Epigenetic modifications of histones in cancer

Zibo Zhao et al.

GENOME BIOLOGY (2019)

Review Oncology

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Prashanth Rawla et al.

WORLD JOURNAL OF ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data

Jia-Jia Xuan et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemistry & Molecular Biology

MODOMICS: a database of RNA modification pathways. 2017 update

Pietro Boccaletto et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

ALKBH5-dependent m6A demethylation controls splicing and stability of long 3 '-UTR mRNAs in male germ cells

Chong Tang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Pharmacology & Pharmacy

Targeting Epigenetics in Cancer

Richard L. Bennett et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)

Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Oncology

Emerging roles of long non-coding RNA in cancer

Anna Sanchez Calle et al.

CANCER SCIENCE (2018)

Review Biochemistry & Molecular Biology

The Human Transcription Factors

Samuel A. Lambert et al.

Article Biochemistry & Molecular Biology

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Rui Su et al.

Article Cell Biology

ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation

Yuan He et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Immunology

Regulation and Function of the PD-L1 Checkpoint

Chong Sun et al.

IMMUNITY (2018)

Article Biochemistry & Molecular Biology

Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal

Jing Wen et al.

MOLECULAR CELL (2018)

Article Biochemistry & Molecular Biology

N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential

Dandan Yang et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Multidisciplinary Sciences

Gene therapy comes of age

Cynthia E. Dunbar et al.

SCIENCE (2018)

Review Cell & Tissue Engineering

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

Lan Thi Hanh Phi et al.

STEM CELLS INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

Differential m(6)A, m(6)A(m), and m(1)A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm

Jiangbo Wei et al.

MOLECULAR CELL (2018)

Article Multidisciplinary Sciences

mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis

Junho Choe et al.

NATURE (2018)

Letter Oncology

Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia

Chau-To Kwok et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

Article Multidisciplinary Sciences

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

Isaia Barbieri et al.

NATURE (2017)

Article Multidisciplinary Sciences

RNA targeting with CRISPR-Cas13

Omar O. Abudayyeh et al.

NATURE (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Biochemistry & Molecular Biology

N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein

Nian Liu et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Cell & Tissue Engineering

The DEAD-Box RNA Helicase DDX3 Interacts with m(6)A RNA Demethylase ALKBH5

Abdullah Shah et al.

STEM CELLS INTERNATIONAL (2017)

Review Oncology

Understanding and targeting resistance mechanisms in NSCLC

Julia Rotow et al.

NATURE REVIEWS CANCER (2017)

Article Biochemistry & Molecular Biology

The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention

Kathryn E. Pendleton et al.

Article Cell Biology

Extensive translation of circular RNAs driven by N6-methyladenosine

Yun Yang et al.

CELL RESEARCH (2017)

Article Oncology

The Microenvironmental Landscape of Brain Tumors

Daniela F. Quail et al.

CANCER CELL (2017)

Letter Cell Biology

Cytoplasmic m6A reader YTHDF3 promotes mRNA translation

Ang Li et al.

CELL RESEARCH (2017)

Review Oncology

YAP/TAZ at the Roots of Cancer

Francesca Zanconato et al.

CANCER CELL (2016)

Article Chemistry, Multidisciplinary

Adeno-associated virus (AAV) vectors in cancer gene therapy

Jorge L. Santiago-Ortiz et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Biochemistry & Molecular Biology

Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing

Wen Xiao et al.

MOLECULAR CELL (2016)

Article Biochemistry & Molecular Biology

The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells

Shuibin Lin et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

Filippos Kottakis et al.

NATURE (2016)

Article Multidisciplinary Sciences

m6A RNA methylation promotes XIST-mediated transcriptional repression

Deepak P. Patil et al.

NATURE (2016)

Article Multidisciplinary Sciences

Sleep deprivation and false confessions

Steven J. Frenda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector

Omar O. Abudayyeh et al.

SCIENCE (2016)

Review Biochemistry & Molecular Biology

Temozolomide resistance in glioblastoma multiforme

Sang Y. Lee

GENES & DISEASES (2016)

Article Biochemistry & Molecular Biology

5′ UTR m6A Promotes Cap-Independent Translation

Kate D. Meyer et al.

Review Biochemistry & Molecular Biology

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Fa-Xing Yu et al.

Article Biochemistry & Molecular Biology

HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

Claudio R. Alarcon et al.

Article Biochemistry & Molecular Biology

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

Xiao Wang et al.

Review Cell Biology

Cancer stem cells in glioblastoma

Justin D. Lathia et al.

GENES & DEVELOPMENT (2015)

Article Multidisciplinary Sciences

N6-methyladenosine marks primary microRNAs for processing

Claudio R. Alarcon et al.

NATURE (2015)

Article Biochemical Research Methods

Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome

Bastian Linder et al.

NATURE METHODS (2015)

Review Medicine, General & Internal

Acute Myeloid Leukemia

Hartmut Doehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5

Yue Huang et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Pharmacology & Pharmacy

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

Bo Hong et al.

CURRENT DRUG TARGETS (2014)

Article Biochemistry & Molecular Biology

Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition

Chong Feng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

N6-methyladenosine-dependent regulation of messenger RNA stability

Xiao Wang et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

Jianzhao Liu et al.

NATURE CHEMICAL BIOLOGY (2014)

Review Genetics & Heredity

Gene expression regulation mediated through reversible m6A RNA methylation

Ye Fu et al.

NATURE REVIEWS GENETICS (2014)

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Article Biochemistry & Molecular Biology

ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility

Guanqun Zheng et al.

MOLECULAR CELL (2013)

Article Chemistry, Medicinal

Dynamic Combinatorial Mass Spectrometry Leads to Inhibitors of a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase

Esther C. Y. Woon et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

The mRNA-Bound Proteome and Its Global Occupancy Profile on Protein-Coding Transcripts

Alexander G. Baltz et al.

MOLECULAR CELL (2012)

Article Multidisciplinary Sciences

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Dan Dominissini et al.

NATURE (2012)

Review Oncology

Genetics of adult glioma

McKinsey L. Goodenberger et al.

CANCER GENETICS (2012)

Article Biochemistry & Molecular Biology

N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

Guifang Jia et al.

NATURE CHEMICAL BIOLOGY (2011)

Review Biotechnology & Applied Microbiology

Epigenetic modifications and human disease

Anna Portela et al.

NATURE BIOTECHNOLOGY (2010)

Article Cell Biology

Expression and sub-cellular localization of human ABH family molecules

Kazutake Tsujikawa et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)

Article Biochemistry & Molecular Biology

Prevalence and specificity of LKB1 genetic alterations in lung cancers

S. Matsumoto et al.

ONCOGENE (2007)

Review Biochemistry & Molecular Biology

Hypoxia-inducible factors, stem cells, and cancer

Brian Keith et al.

Article Multidisciplinary Sciences

AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli

PO Falnes et al.

NATURE (2002)

Article Multidisciplinary Sciences

Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage

SC Trewick et al.

NATURE (2002)